Ventolin HFA: Fast-Acting Relief for Asthma and Bronchospasm
| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $56.76 (0%) | 🛒 Add to cart |
| 90 | $0.87 | $85.14 $78.26 (8%) | 🛒 Add to cart |
| 120 | $0.80 | $113.52 $96.32 (15%) | 🛒 Add to cart |
| 180 | $0.71 | $170.28 $127.28 (25%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $340.56 $193.50 (43%) | 🛒 Add to cart |
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.35 | $40.42 (0%) | 🛒 Add to cart |
| 60 | $1.19 | $80.84 $71.38 (12%) | 🛒 Add to cart |
| 90 | $1.03 | $121.26 $92.88 (23%) | 🛒 Add to cart |
| 120 | $0.86 | $161.68 $103.20 (36%) | 🛒 Add to cart |
| 180 | $0.79 | $242.52 $142.76 (41%) | 🛒 Add to cart |
| 270 | $0.69 | $363.78 $186.62 (49%) | 🛒 Add to cart |
| 360 | $0.63
Best per pill | $485.04 $227.04 (53%) | 🛒 Add to cart |
Synonyms | |||
Ventolin HFA (albuterol sulfate) is a trusted, short-acting beta-agonist bronchodilator delivered via metered-dose inhaler, designed for the rapid relief of acute bronchospasm. It is a first-line rescue medication indicated for the treatment and prevention of bronchospasm in patients with reversible obstructive airway disease, including asthma and exercise-induced bronchospasm. By selectively targeting beta-2 adrenergic receptors in the airway smooth muscle, it promotes rapid bronchodilation, facilitating easier breathing within minutes. Its consistent delivery system and well-established safety profile make it an essential component of asthma management protocols worldwide.
Features
- Contains albuterol sulfate, a selective short-acting beta2-adrenergic receptor agonist (SABA)
- Delivered via a hydrofluoroalkane (HFA) propelled metered-dose inhaler
- Each actuation delivers 90 mcg of albuterol (from the valve)
- Rapid onset of action, typically within 5–15 minutes
- Effects last for approximately 4 to 6 hours
- Portable, pressurized canister with a dose counter to track remaining medication
- Requires priming before first use and if not used for extended periods
Benefits
- Provides rapid relief from acute asthma symptoms and bronchospasm
- Helps prevent exercise-induced bronchospasm when used prophylactically
- Restores airway patency, improving oxygenation and reducing respiratory effort
- Enables quick intervention during asthma exacerbations, potentially reducing emergency visits
- Easy-to-use inhaler format supports adherence and prompt administration
- Trusted, decades-long clinical history with extensive safety data
Common use
Ventolin HFA is primarily used for the relief of acute bronchospasm in conditions characterized by reversible airway obstruction. This includes asthma, where it serves as a rescue medication during acute attacks or worsening symptoms. It is also indicated for the prevention of exercise-induced bronchospasm (EIB) when administered 15–30 minutes prior to physical exertion. In clinical practice, it may be used off-label in other obstructive pulmonary conditions, such as chronic obstructive pulmonary disease (COPD), during episodes of acute bronchoconstriction, though it is not a substitute for long-term control medications.
Dosage and direction
The dosage of Ventolin HFA must be individualized based on severity of symptoms and patient response. For treatment of acute bronchospasm in adults and children 4 years of age and older, the usual dose is 2 inhalations every 4 to 6 hours. In some cases, 1 inhalation every 4 hours may be sufficient. For prevention of exercise-induced bronchospasm, the recommended dose is 2 inhalations 15 to 30 minutes before exercise. It is critical to prime the inhaler before first use or if it has not been used for more than 2 weeks by releasing 4 test sprays into the air away from the face. Shake well before each use. Exceeding the recommended dosage without medical supervision increases the risk of adverse effects.
Precautions
Patients should be advised that Ventolin HFA is a rescue medication and not intended for regular scheduled use. Increasing need for Ventolin may indicate deteriorating asthma control, necessitating re-evaluation of the patient’s maintenance therapy. Use with caution in patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension), hyperthyroidism, diabetes, or seizure disorders. Paradoxical bronchospasm may occur; if this happens, discontinue use immediately and institute alternative therapy. Hypokalemia may occur, particularly in susceptible patients or with high doses. Be aware that the HFA propellant is under pressure—do not puncture or incinerate the canister.
Contraindications
Ventolin HFA is contraindicated in patients with a history of hypersensitivity to albuterol or any component of the formulation. It should not be used for the prevention of preterm labor due to the risk of maternal pulmonary edema. Caution is advised in patients with known or suspected pheochromocytoma due to the potential for exaggerated adrenergic response. Not recommended as the sole agent for patients with status asthmaticus or other acute episodes where intensive measures are required.
Possible side effect
Common side effects include palpitations, tachycardia, chest pain, tremors, nervousness, dizziness, headache, throat irritation, and cough. Less frequently, patients may experience hypokalemia, hypertension, hypotension, muscle cramps, insomnia, nausea, vomiting, and drying or irritation of the oropharynx. Paradoxical bronchospasm (wheezing) immediately following administration occurs rarely but requires immediate discontinuation. Allergic reactions including rash, urticaria, and angioedema have been reported.
Drug interaction
Concomitant use with other sympathomimetic agents may potentiate cardiovascular effects. Beta-blockers (particularly non-selective ones) may antagonize the bronchodilating effect of albuterol and produce severe bronchospasm. Use with monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants may potentiate the cardiovascular effects of albuterol. Diuretics or corticosteroids may enhance the hypokalemic effect of albuterol. Use caution with digitalis, as hypokalemia may increase the risk of digitalis-induced arrhythmias.
Missed dose
As Ventolin HFA is used on an as-needed basis for symptom relief, there is no fixed dosing schedule, and the concept of a “missed dose” does not typically apply. However, for prophylactic use (e.g., before exercise), if a dose is missed and the activity has already begun, it may be administered as soon as remembered, provided the next dose is not due shortly. Do not double the dose to make up for a missed one.
Overdose
Overdose may lead to exaggerated adrenergic effects including angina, hypertension or hypotension, tachycardia (with rates up to 200 beats per minute), arrhythmias, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, fatigue, malaise, insomnia, hypokalemia, and hyperglycemia. Cardiac arrest and death may occur. Treatment is supportive and symptomatic. Cardioselective beta-blockers may be considered but should be used with caution in patients with bronchospastic disease due to risk of inducing bronchospasm.
Storage
Store at room temperature between 15°C and 25°C (59°F and 77°F). Avoid freezing and exposure to extreme heat or direct sunlight. The canister is under pressure—do not puncture or incinerate, even when apparently empty. Keep out of reach of children. The inhaler should be discarded when the counter reads “000” or after 3 months from removal from the foil pouch, whichever comes first.
Disclaimer
This information is intended for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and individualized treatment recommendations. Do not initiate, discontinue, or change the dosage of any medication without professional supervision. The content provided is based on current pharmacological knowledge but may not encompass all possible uses, directions, precautions, or interactions.
Reviews
“Ventolin has been a lifesaver during my asthma attacks for over a decade. The speed of relief is consistent and reliable.” — Maria K., diagnosed with asthma
“As a pulmonologist, I consistently prescribe Ventolin HFA for its rapid onset and predictable efficacy in acute bronchospasm. The dose counter is a practical addition for patient self-management.” — Dr. Evan R., Pulmonologist
“I use it preventively before running and it completely eliminates my exercise-induced symptoms. The portability makes it easy to carry at all times.” — James L., athlete with EIB
“After trying other rescue inhalers, I find Ventolin has the least jittery side effects for me while still providing quick relief.” — Susan T., COPD patient